Now offering employer-sponsored weight loss, hormone & longevity programs — Talk to our team →
Weight loss, hormone therapy, and longevity programs — clinically supervised and delivered to your workforce. At-home testing, telehealth support, and measurable outcomes.
Trusted by employers and health plans nationwide
Investing in workforce health isn't just the right thing to do — it's the smartest business decision you can make. Here's why leading employers are prioritizing clinical health programs.
Blue Cross Blue Shield Massachusetts posted a $400M operating loss in 2024 — GLP-1 drugs alone drove $300M of that, representing 20% of total pharmacy costs. Managed programs like ours prevent this.
Source: Pearson et al., J Comp Eff Res, 2025
Two-thirds of large employers (17.1M employees) now cover GLP-1 medications, with another 19% considering it. If you don’t offer it, your competitors do.
Source: Pearson et al., J Comp Eff Res, 2025
Connecticut’s state employee carve-out program achieved 10% average weight loss — 12% for GLP-1 users — with 50% of patients managed on lower-cost alternatives.
Source: Flyte Health / CT State, 2025
Employer carve-out programs report a 3-to-1 ROI on clinical health investments. Managed programs reduce claims, absenteeism, and presenteeism simultaneously.
Source: Pearson et al., J Comp Eff Res, 2025
Clinical programs with step therapy manage half of patients on lower-cost medications — phentermine/topiramate at $1,465/yr vs. $9,000+ for GLP-1s — delivering results at a fraction of the cost.
Source: Pearson et al., J Comp Eff Res, 2025
U.S. GLP-1 spending could exceed $100 billion annually within 5 years. Without managed programs, employer costs quadruple — Colorado’s state plan saw exactly that from 2023 to 2024.
Source: Pearson et al., J Comp Eff Res, 2025
The average employer sees 3–6x return on every dollar invested in clinical health programs.
Calculate Your ROIFour categories backed by clinical evidence — each filling a gap that traditional benefits leave wide open.
FDA-backed GLP-1 programs with brand-name and compounded options. Semaglutide and tirzepatide with personalized dosing, ongoing monitoring, and clinical support — delivered in days, not months.
14.9% average body weight loss with semaglutide 2.4mg — 86% of patients lost 5%+ body weight
STEP 1 Trial — New England Journal of Medicine, 2021
Up to 22.5% body weight loss with tirzepatide 15mg — 63% of patients achieved 20%+ reduction
SURMOUNT-1 Trial — New England Journal of Medicine, 2022
GLP-1 patients saw a 40%+ reduction in major cardiac events and 7% lower medical costs within 2 years
Aon Employer Study, 2025
Losing 5% body weight saves ~$670/year per employee in healthcare costs; 25% loss saves $2,849/year
JAMA — Cost Analysis
43% of large employers (5,000+ workers) now cover GLP-1s for weight loss, up from 28% in 2024
KFF/Peterson Health System Tracker, 2025
Virtual mental health care your employees can actually access — same-week appointments, no referral hoops, and structured programs for the conditions that impact work the most.
12 billion working days lost annually to depression and anxiety, costing $1 trillion/year in lost productivity
World Health Organization — Mental Health at Work, 2024
Workers with poor mental health miss ~12 days/year vs. 2.5 days for those with good mental health — costing $47.6B/year
Gallup Workplace Study
Every $1 spent on mental health programs returns $5.39 in reduced absenteeism, presenteeism, and turnover
CuraLinc Healthcare — Peer-Reviewed Study (166,000+ cases)
Depressed employees are 35% less productive and miss an average of 31.4 workdays per year
American Psychiatric Association — Workplace Mental Health
80%+ of virtual therapy participants report outcomes comparable to or better than in-office sessions
JMIR Mental Health, 2024
Lab-verified testosterone therapy for men and comprehensive menopause care for women — the high-impact programs that traditional insurance almost never covers well.
10–40% of adult men have testosterone deficiency — projected 6.5 million U.S. men affected by 2025
Journal of Clinical Endocrinology & Metabolism
13.4% of women report adverse work outcomes from menopause; those with untreated symptoms have 57% greater productivity loss
Mayo Clinic Proceedings, 2023
Global productivity losses from menopausal symptoms estimated at $150 billion; healthcare costs exceed $600 billion
AARP Research
1 in 10 women leave the workforce entirely due to menopause symptoms; 25% consider leaving
Mayo Clinic — Menopause & Workplace Study, 2023
HRT is the most efficacious treatment for vasomotor and urogenital symptoms with additional bone density benefits
2025 Meta-Analysis — PMC
Proactive wellness programs that go beyond sick care — NAD+, metabolic optimization, and anti-aging therapies that position your company as a forward-thinking employer.
Global anti-aging market is ~$80B today, projected to exceed $120 billion by 2030 (7% CAGR)
Precedence Research / Grand View Research, 2025
Companies with highly effective wellness programs are 40% more likely to report better financial performance
Harvard Business Review — Wellness ROI
Oral NMN/NR supplementation consistently elevates circulating NAD+ by 130–150% in clinical trials
2025 PRISMA Systematic Review — ScienceDirect (33 human studies)
Johnson & Johnson's 10+ year wellness program delivered $2.71 ROI per $1 spent; GE reported $4 per $1
Harvard Business Review — Corporate Case Studies
95% of companies tracking wellness ROI report positive returns; two-thirds see at least $2 back per $1 spent
Wellhub Global Survey — 2,000 HR Leaders, 2024
We focus on the high-impact programs that traditional insurance either excludes, underfunds, or makes nearly impossible to access.
The insurance gap: Insurance rarely covers GLP-1 medications — or makes it a months-long prior authorization nightmare.
Personalized, physician-guided GLP-1 programs that employees can start in days, not months. Brand-name and compounded options with ongoing clinical support.
Employees get access to semaglutide and tirzepatide without fighting their insurance company for months.
Multiple titration tracks matched to each person's history and tolerance — not a one-size-fits-all approach.
Regular check-ins, side-effect management, and dose adjustments keep employees on track long-term.
Real clinical trial results and employer ROI data — sourced from peer-reviewed studies and Fortune 500 case studies.
% body weight lost — clinical trial results
STEP 1 control
STEP 1 — NEJM, 2021
SURMOUNT-1 — NEJM, 2022
SURMOUNT-1 — NEJM, 2022
% of patients achieving key outcomes
lost 5%+ weight
Semaglutide (STEP 1)
lost 10%+ weight
Semaglutide (STEP 1)
lost 20%+ weight
Tirzepatide 15mg
virtual = in-person
Telehealth outcomes
Peer-reviewed studies & employer case data
Source: Calibrate / Aon
Source: CuraLinc (peer-reviewed)
Source: Harvard Business Review
95% of companies tracking wellness ROI report positive returns — nearly two-thirds see at least $2 back per $1. — Wellhub, 2024
What untreated conditions cost employers
extra medical claims vs. healthy-weight peers
missed per depressed employee — 35% less productive
in productivity losses; $600B+ in healthcare
lost to unplanned absences in the U.S.
$1 trillion per year lost globally to depression and anxiety alone. — WHO
GLP-1sGLP-1 Weight Loss
43% of large employers
up from 28% in 2024
Mental HealthFast Mental Health
~5% EAP utilization
80%+ with telehealth
HRTHormone Therapy
~12% adequate coverage
39% wait until severe
LongevityLongevity / NAD+
0% coverage
$120B+ market by 2030
JoeyMed fills the gaps that traditional insurance leaves wide open — giving your employees access to the care that actually moves the needle.
Whether it's weight loss, hormone therapy, or longevity — our platform guides employees from intake through ongoing care.
Employees enroll through a streamlined intake portal. We handle eligibility verification, consent, and onboarding — zero admin burden for your HR team.
For programs requiring labs, screening kits ship directly to employees. Weight loss and longevity programs use streamlined digital intake.
Specialist clinicians review results and determine eligibility. Prescriptions are tailored to each program and delivered to the employee's door.
Monthly prescriptions, regular lab monitoring, weekly check-ins, 24/7 support, and clinician-guided dosage optimization — all through the JoeyMed app.
Our programs are designed to deliver measurable outcomes with industry-leading engagement.
Average weight loss in the first 6 months of the program
Program retention rate — employees stay and see results
Clinical support for side-effect management and care
Obesity, hormonal imbalances, and untreated health conditions cost your organization in premiums, productivity, and turnover. JoeyMed gives you the infrastructure to change that.
We handle enrollment, eligibility, screening kit logistics, clinical review, prescriptions, and ongoing support. Your HR team stays focused on what matters.
Healthier employees file fewer chronic disease claims. Our programs help reduce your group insurance costs by addressing obesity, hormonal imbalances, and metabolic risk factors.
Aggregated, de-identified dashboards showing enrollment, engagement, outcomes, and retention — giving you clear visibility into program ROI.
Every prescription, titration, and follow-up is managed by licensed specialists. Clinical excellence means better outcomes and fewer liability concerns.
Offer a branded employee experience through our mobile app — customizable with your company colors, messaging, and wellness goals.
Licensed providers nationwide. At-home kits shipped anywhere in the US. Roll out to distributed teams without geographic limitations.
Employees managing chronic conditions miss fewer days. Programs targeting weight, hormones, and energy directly reduce sick days and presenteeism.
GLP-1, HRT, and wellness benefits are the most in-demand perks in 2026. Offering them positions you as a forward-thinking employer.
Track weight loss trends, medication adherence, retention rates, and engagement scores — tied to real business metrics your C-suite cares about.
The JoeyMed app powers every step from screening to sustained health management. Clinically guided. Always accessible.
Live proctored screening with step-by-step instructions. Complete the test kit from home with real-time clinical guidance.
Visual dashboards showing weight trends, medication adherence, and health milestones — keeping employees motivated.
Direct messaging with care teams, automated medication reminders, and scheduled check-in prompts.
Round-the-clock access to clinical support for side-effect management, dosing questions, and care guidance.
Recommendations tailored to each employee's health data, lab results, and treatment progress.
Whether you're a startup or a Fortune 500, we have a plan that fits your workforce needs and budget.
For companies exploring health benefits
For employers investing in workforce health
For large organizations & health plans
We offer four program categories: (1) Individualized Weight Loss with compounded GLP-1/GIP, (2) Brand-Name Weight Loss with Wegovy/Ozempic/Zepbound/Mounjaro only, (3) Testosterone Replacement Therapy (TRT), (4) Female Hormone Replacement Therapy (HRT) for menopause/perimenopause, and (5) Anti-Aging & Longevity. All are clinically supervised and delivered via telemedicine.
For programs requiring labs (TRT, Female HRT), we ship screening kits directly to enrolled employees. They complete at-home blood collection guided by a live certified proctor via telehealth. Results are clinically reviewed, and eligible employees receive their prescription. Weight loss and longevity programs typically don't require labs.
Individualized WL uses compounded semaglutide/tirzepatide with three titration tracks (Alternative, Rapid, Twice-Weekly) and symptom-targeted additives for personalization. Brand-Name WL uses only FDA-approved brand medications (Wegovy, Ozempic, Zepbound, Mounjaro) with strict eligibility — no compounded products. Both include safety screening and ongoing follow-ups.
TRT: Testosterone Lotion (2-20mg/ml), Testosterone Lotion 5-10%, and Testosterone Cypionate injections — all requiring mandatory low-T lab confirmation. Female HRT: Estrogen therapy (Estrogel, Divigel, Vivelle-Dot patches, oral Estrace, Evamist spray), Progesterone (Prometrium, Provera, Norethindrone), and Vaginal Estrogen for genitourinary symptoms. Female HRT does not include controlled substances like testosterone.
We offer flexible cost models: fully employer-subsidized, partially subsidized (cost-sharing), or employee-paid. We can also integrate with your existing PBM (like CVS Caremark). Contact our team for custom pricing based on your workforce size, selected programs, and coverage model.
Our Population Health Dashboard provides aggregated, de-identified analytics including enrollment rates by program, retention, outcomes, medication adherence, and engagement scores. Enterprise plans include custom ROI reporting and executive health briefings.
All services are fully HIPAA-compliant. Employers receive only aggregated, de-identified data — never individual employee health information. Our platform uses enterprise-grade encryption and follows strict healthcare data governance protocols.
Join the growing number of employers who are investing in clinically supervised health programs. Let's build a healthier, more productive workforce together.
